SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Kulkarni Shashikant – ‘3/A’ for 7/7/22 re: Neogenomics Inc.

On:  Wednesday, 9/7/22, at 6:41pm ET   ·   For:  7/7/22   ·   As:  Officer   ·   Accession #:  1077183-22-150   ·   File #:  1-35756

Previous ‘3’:  ‘3’ on 7/15/22 for 7/7/22   ·   Latest ‘3’:  This Filing

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/07/22  Kulkarni Shashikant               3/A        Officer     1:5K   Neogenomics Inc.                  Neogenomics Inc.

Amendment to Initial Statement of Beneficial Ownership of Securities by an Insider   —   Form 3   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 3/A         Amendment to Initial Statement of Beneficial        HTML      6K 
                Ownership of Securities by an Insider --                         
                wf-form3a_166259047950967.xml/2.6


        

This ‘3/A’ Document is an XML Data File that may be rendered in various formats:

  Form 3    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
XML Data rendering:  Amendment to Initial Statement of Beneficial Ownership of Securities by an Insider — wf-form3a_166259047950967.xml/2.6
 
                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<ownershipDocument>
<schemaVersion> X0206 </schemaVersion>
<documentType> 3/A </documentType>
<periodOfReport> 2022-07-07 </periodOfReport>
<dateOfOriginalSubmission> 2022-07-15 </dateOfOriginalSubmission>
<noSecuritiesOwned> 0 </noSecuritiesOwned>
<issuer>
<issuerCik> 0001077183 </issuerCik>
<issuerName> NEOGENOMICS INC </issuerName>
<issuerTradingSymbol> NEO </issuerTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik> 0001936800 </rptOwnerCik>
<rptOwnerName> Kulkarni Shashikant </rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerStreet1> 9490 NEOGENOMICS WAY </rptOwnerStreet1>
<rptOwnerStreet2></rptOwnerStreet2>
<rptOwnerCity> FORT MYERS </rptOwnerCity>
<rptOwnerState> FL </rptOwnerState>
<rptOwnerZipCode> 33912 </rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector> 0 </isDirector>
<isOfficer> 1 </isOfficer>
<isTenPercentOwner> 0 </isTenPercentOwner>
<isOther> 0 </isOther>
<officerTitle> President of Lab Operations </officerTitle>
<otherText></otherText>
</reportingOwnerRelationship>
</reportingOwner>
<nonDerivativeTable>
<nonDerivativeHolding>
<securityTitle>
<value> Common Stock </value>
</securityTitle>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 61728 </value>
<footnoteId id="F1"/>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeHolding>
</nonDerivativeTable>
<derivativeTable>
<derivativeHolding>
<securityTitle>
<value> Stock Option (Right to Buy) </value>
</securityTitle>
<conversionOrExercisePrice>
<value> 12.15 </value>
</conversionOrExercisePrice>
<exerciseDate>
<footnoteId id="F2"/>
</exerciseDate>
<expirationDate>
<value> 2029-04-01 </value>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value> Common Stock </value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value> 132744.0 </value>
<footnoteId id="F3"/>
</underlyingSecurityShares>
</underlyingSecurity>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</derivativeHolding>
</derivativeTable>
<footnotes>
<footnote id="F1"> This Amended Form 3 reflects an additional 20,576 restricted stock awards granted on April 1, 2022 that were omitted due to administrative error on the original Form 3 filed on July 15, 2022 and the subsequent Form 4 filed on August 3, 2022. </footnote>
<footnote id="F2"> On April 1, 2022, Dr. Kulkarni was granted 132,744 stock options. These options vest ratably over the first four anniversary dates of the grant date. </footnote>
<footnote id="F3"> This Amended Form 3 reflects an additional 44,248 stock options granted on April 1, 2022 that were omitted due to administrative error on the original Form 3 filed on July 15, 2022 and the subsequent Form 4 filed on August 3, 2022. </footnote>
</footnotes>
<remarks></remarks>
<ownerSignature>
<signatureName> /s/ Ali Olivo, Attorney-in-Fact </signatureName>
<signatureDate> 2022-09-07 </signatureDate>
</ownerSignature>
</ownershipDocument>


↑Top
Filing Submission 0001077183-22-000150   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., Apr. 28, 3:00:40.2pm ET